Literature DB >> 31563573

Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries.

Matt S Zinter1, Brent R Logan2, Caitrin Fretham3, Anil Sapru4, Allistair Abraham5, Mahmoud D Aljurf6, Staci D Arnold7, Andrew Artz8, Jeffery J Auletta9, Saurabh Chhabra10, Edward Copelan11, Christine Duncan12, Robert P Gale13, Eva Guinan14, Peiman Hematti15, Amy K Keating16, David I Marks17, Richard Olsson18, Bipin N Savani19, Celalettin Ustun20, Kirsten M Williams21, Marcelo C Pasquini2, Christopher C Dvorak22.   

Abstract

Critically ill pediatric allogeneic hematopoietic cell transplant (HCT) patients may benefit from early and aggressive interventions aimed at reversing the progression of multiorgan dysfunction. Therefore, we evaluated 25 early risk factors for pediatric intensive care unit (PICU) mortality to improve mortality prognostication. We merged the Virtual Pediatric Systems and Center for International Blood and Marrow Transplant Research databases and analyzed 936 critically ill patients ≤21 years of age who had undergone allogeneic HCT and subsequently required PICU admission between January 1, 2009, and December 31, 2014. Of 1532 PICU admissions, the overall PICU mortality rate was 17.4% (95% confidence interval [CI], 15.6% to 19.4%) but was significantly higher for patients requiring mechanical ventilation (44.0%), renal replacement therapy (56.1%), or extracorporeal life support (77.8%). Mortality estimates increased significantly the longer that patients remained in the PICU. Of 25 HCT- and PICU-specific characteristics available at or near the time of PICU admission, moderate/severe pre-HCT renal injury, pre-HCT recipient cytomegalovirus seropositivity, <100-day interval between HCT and PICU admission, HCT for underlying acute myeloid leukemia, and greater admission organ dysfunction as approximated by the Pediatric Risk of Mortality 3 score were each independently associated with PICU mortality. A multivariable model using these components identified that patients in the top quartile of risk had 3 times greater mortality than other patients (35.1% versus 11.5%, P < .001, classification accuracy 75.2%; 95% CI, 73.0% to 77.4%). These data improve our working knowledge of the factors influencing the progression of critical illness in pediatric allogeneic HCT patients. Future investigation aimed at mitigating the effect of these risk factors is warranted.
Copyright © 2019 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hematopoietic stem cell transplantation; Intensive care units; Organ dysfunction scores; Pediatric; Prognosis; Survival analysis

Mesh:

Year:  2019        PMID: 31563573      PMCID: PMC6943183          DOI: 10.1016/j.bbmt.2019.09.027

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  47 in total

1.  Critically ill allogenic HSCT patients in the intensive care unit: a systematic review and meta-analysis of prognostic factors of mortality.

Authors:  Colombe Saillard; Michael Darmon; Magali Bisbal; Antoine Sannini; Laurent Chow-Chine; Marion Faucher; Etienne Lengline; Norbert Vey; Didier Blaise; Elie Azoulay; Djamel Mokart
Journal:  Bone Marrow Transplant       Date:  2018-04-27       Impact factor: 5.483

2.  AKI in hospitalized children: comparing the pRIFLE, AKIN, and KDIGO definitions.

Authors:  Scott M Sutherland; John J Byrnes; Manish Kothari; Christopher A Longhurst; Sanjeev Dutta; Pablo Garcia; Stuart L Goldstein
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-03       Impact factor: 8.237

3.  The outcomes and treatment burden of childhood acute myeloid leukaemia in Australia, 1997-2008: A report from the Australian Paediatric Cancer Registry.

Authors:  Steven A Foresto; Danny R Youlden; Peter D Baade; Andrew R Hallahan; Joanne F Aitken; Andrew S Moore
Journal:  Pediatr Blood Cancer       Date:  2015-04-08       Impact factor: 3.167

4.  Early changes in SOFA score as a prognostic factor in pediatric oncology patients requiring mechanical ventilatory support.

Authors:  Eun Ju Ha; Seonguk Kim; Hyun Seung Jin; Keun Wook Bae; Ho Joon Lim; Jong Jin Seo; Seong Jong Park
Journal:  J Pediatr Hematol Oncol       Date:  2010-11       Impact factor: 1.289

5.  Effect of Early Intervention on Long-Term Outcomes of Critically Ill Cancer Patients Admitted to ICUs.

Authors:  Dae-Sang Lee; Gee Young Suh; Jeong-Am Ryu; Chi Ryang Chung; Jeong Hoon Yang; Chi-Min Park; Kyeongman Jeon
Journal:  Crit Care Med       Date:  2015-07       Impact factor: 7.598

6.  Outcome of pediatric hematopoietic stem cell transplant recipients requiring mechanical ventilation.

Authors:  François Aspesberro; Katherine A Guthrie; Ann E Woolfrey; Thomas V Brogan; Joan S Roberts
Journal:  J Intensive Care Med       Date:  2012-08-17       Impact factor: 3.510

7.  Emergency management of children with severe sepsis in the United Kingdom: the results of the Paediatric Intensive Care Society sepsis audit.

Authors:  D P Inwald; R C Tasker; M J Peters; S Nadel
Journal:  Arch Dis Child       Date:  2009-01-08       Impact factor: 3.791

8.  Clinical outcomes of children receiving intensive cardiopulmonary support during hematopoietic stem cell transplant.

Authors:  Christine N Duncan; Leslie E Lehmann; Ira M Cheifetz; Kristin Greathouse; Ann E Haight; Mark W Hall; Amber Herschberger; Katherine S Hill; Jerelyn R Moffet; R Ray Morrison; Angela L Norris; Aleksandra Petrovic; Debra A Spear; Marie E Steiner; Julie-An M Talano; Robert F Tamburro; John Wagner; Jennifer McArthur
Journal:  Pediatr Crit Care Med       Date:  2013-03       Impact factor: 3.624

9.  Acute Kidney Injury and the Risk of Mortality in Children Undergoing Hematopoietic Stem Cell Transplantation.

Authors:  Sarah J Kizilbash; Clifford E Kashtan; Blanche M Chavers; Qing Cao; Angela R Smith
Journal:  Biol Blood Marrow Transplant       Date:  2016-03-29       Impact factor: 5.742

10.  Pediatric Hematopoietic Stem Cell Transplant and Intensive Care: Have Things Changed?

Authors:  Corrine R Balit; Rachael Horan; Tavey Dorofaeff; Helena Frndova; John Doyle; Peter N Cox
Journal:  Pediatr Crit Care Med       Date:  2016-03       Impact factor: 3.624

View more
  10 in total

Review 1.  Early pulmonary complications related to cancer treatment in children.

Authors:  Cara E Morin; Morgan P McBee; Lama Elbahlawan; Lindsay M Griffin; Gabriela M Maron; HaiThuy N Nguyen; Akshay Sharma; Elizabeth J Snyder; Jean Jeudy
Journal:  Pediatr Radiol       Date:  2022-07-02

2.  Should We Intubate Pediatric Hematopoietic Cell Transplant Patients With Respiratory Failure Sooner?

Authors:  Caitlin Hurley; Matt S Zinter
Journal:  Crit Care Med       Date:  2022-06-13       Impact factor: 9.296

3.  A model for building a national, patient-driven database to track contraceptive use in women with rare diseases.

Authors:  Tatiana Josephy; Deena R Loeffler; Molly Pam; Emily M Godfrey
Journal:  J Am Med Inform Assoc       Date:  2022-01-12       Impact factor: 7.942

4.  Pulmonary Complications of Pediatric Hematopoietic Cell Transplantation. A National Institutes of Health Workshop Summary.

Authors:  Robert F Tamburro; Kenneth R Cooke; Stella M Davies; Samuel Goldfarb; James S Hagood; Ashok Srinivasan; Marie E Steiner; Dennis Stokes; Nancy DiFronzo; Nahed El-Kassar; Nonniekaye Shelburne; Aruna Natarajan
Journal:  Ann Am Thorac Soc       Date:  2021-03

5.  The pulmonary metatranscriptome prior to pediatric HCT identifies post-HCT lung injury.

Authors:  Matt S Zinter; Caroline A Lindemans; Birgitta A Versluys; Madeline Y Mayday; Sara Sunshine; Gustavo Reyes; Marina Sirota; Anil Sapru; Michael A Matthay; Sandhya Kharbanda; Christopher C Dvorak; Jaap J Boelens; Joseph L DeRisi
Journal:  Blood       Date:  2021-03-25       Impact factor: 22.113

6.  Candidacy for Extracorporeal Life Support in Children After Hematopoietic Cell Transplantation: A Position Paper From the Pediatric Acute Lung Injury and Sepsis Investigators Network's Hematopoietic Cell Transplant and Cancer Immunotherapy Subgroup.

Authors:  Matt S Zinter; Jennifer McArthur; Christine Duncan; Roberta Adams; Erin Kreml; Heidi Dalton; Hisham Abdel-Azim; Courtney M Rowan; Shira J Gertz; Kris M Mahadeo; Adrienne G Randolph; Prakadeshwari Rajapreyar; Marie E Steiner; Leslie Lehmann
Journal:  Pediatr Crit Care Med       Date:  2022-03-01       Impact factor: 3.624

7.  Perspective: A Framework to Screen Pediatric and Adolescent Hematopoietic Cellular Therapy Patients for Organ Dysfunction: Time for a Multi-Disciplinary and Longitudinal Approach.

Authors:  Ali H Ahmad; Kris M Mahadeo
Journal:  Front Oncol       Date:  2021-02-24       Impact factor: 6.244

8.  Retrospective Review of Flexible Bronchoscopy in Pediatric Cancer Patients.

Authors:  Ali H Ahmad; Brandon D Brown; Clark R Andersen; Kris M Mahadeo; Demetrios Petropolous; José A Cortes; Shehla Razvi; Mary Katherine Gardner; Linette J Ewing; Rodrigo E Mejia
Journal:  Front Oncol       Date:  2021-12-14       Impact factor: 6.244

9.  A biomarker panel for risk of early respiratory failure following hematopoietic cell transplantation.

Authors:  Courtney M Rowan; Lincoln Smith; Matthew P Sharron; Laura Loftis; Sapna Kudchadkar; Christine N Duncan; Francis Pike; Paul A Carpenter; David Jacobsohn; Catherine M Bollard; Conrad Russell Y Cruz; Abhijeet Malatpure; Sherif Farag; Jamie Renbarger; Morgan R Little; Phillip R Gafken; Robert A Krance; Kenneth R Cooke; Sophie Paczesny
Journal:  Blood Adv       Date:  2022-03-22

10.  Prognostic factors of pediatric hematopoietic stem cell transplantation recipients admitted to the pediatric intensive care unit.

Authors:  Da Hyun Kim; Eun Ju Ha; Seong Jong Park; Kyung-Nam Koh; Hyery Kim; Ho Joon Im; Won Kyoung Jhang
Journal:  Acute Crit Care       Date:  2021-11-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.